Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
12/2005
12/29/2005WO2005085189A3 Analogues of congo red and evaluation of their anti-prion activity
12/29/2005DE102004026102A1 Verfahren zur Herstellung von 1-Hydroxymethyl-1,3,5-triazapentan, Trihydrochlorid A process for the preparation of 1-hydroxymethyl-1,3,5-triazapentan, trihydrochloride
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005EP1002790B1 Sphingosine analogues
12/28/2005EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
12/22/2005WO2005121066A1 The preparation method of (1 r,2s)-(-)-ephedrine or its hydrochloride
12/22/2005WO2005121065A2 DIAMINE β2 ADRENERGIC RECEPTOR AGONISTS
12/22/2005CA2569395A1 Diamine .beta.2 adrenergic receptor agonists
12/21/2005CN1709858A 4-amino-6-nitro resorcin hydrochloride, and its preparation and use
12/21/2005CN1709857A Choline chloride mixing and producing process
12/21/2005CN1232500C Method for recovering regeneration tower heat quantity
12/15/2005WO2005118525A1 Synthesis of amino-alkoxy-heptanoic alkyl ester
12/15/2005WO2005118522A1 Monomethylphytosphingosine- polyethylenegly col and the composition for anti-cancer containing the same
12/15/2005WO2005118521A1 Monomethylphytosphingosine and the composition for anti-cancer containing the same
12/15/2005WO2005117849A1 Diarylalkanes as potent inhibitors of binuclear enzymes
12/15/2005WO2005117817A1 M-phenylene diamine coupler components
12/15/2005US20050277791 Reacting alpha -substituted ketone such as 1-[4-(benzyloxy)phenyl]-2-bromo-1-propanone with an optically active amine such as (S)-1-phenethylamine to produce mixture of diastereomers of an optically active alpha -substituted aminoketone
12/15/2005DE102004026732A1 m-Phenylendiamin-Kupplerkomponenten m-phenylenediamine coupler components
12/15/2005CA2567914A1 Synthesis of amino-alkoxy-heptanoic alkyl ester
12/15/2005CA2567801A1 Diarylalkanes as potent inhibitors of binuclear enzymes
12/14/2005EP1603862A1 3,3-diarylpropylamine derivatives and processes for isolation thereof
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1603523A1 Compositions useful to prevent in-grown hair arising from shaving
12/14/2005CN1706812A Prepn process of (1R, 2S)-(-)-ephedrine or its hydrochloride
12/14/2005CN1231457C Substituted cycloheptaene and its preparation process and use
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/13/2005US6974883 Process for manufacturing triethanolamine and product obtained
12/13/2005US6974881 Reacting resorcin with fuming sulfuric acid to produce resorcin 2,4,6-trisulfonate, then nitrating to obtain 2-sulfonic acid-4,6-dinitroresorcin; by-product inhibition
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/08/2005WO2005115994A1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof
12/08/2005WO2005115969A1 Method for producing quaternary ammonium compounds
12/08/2005WO2005115968A1 Method for producing 1-hydroxymethyl-1,3,5-triazapentane, trihydrochloride
12/08/2005US20050272822 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
12/08/2005US20050272821 Levalbuterol hydrochloride Polymorph A
12/08/2005US20050272769 8-hydroxy-5-[(R)-1-hydroxy-2-(6-phenethylamino-hexylamino)ethyl]-1H-quinolin-2-one; pulmonary disease: asthma or chronic obstructive pulmonary disease, pre-term labor, a neurological disorder, a cardiac disorder, or inflammation; long duration of action
12/08/2005US20050272674 Selective hydrolysis of acarbose, acarbose derivatives with trifluoroacetic acid, removing the byproducts, i.e., monosaccharides, disaccharides, and trisaccharides; purifying valienamine in presence of ion-exchange resins
12/08/2005US20050272665 Synthesis of alpha-amino-beta-alkoxy-carboxylic acid esters
12/08/2005CA2767376A1 Novel 7,7-disubstituted derivatives of (5h,9h)-6,8-dioxabenzocycloheptene, preparation method thereof and use of same in the synthesis of non-steroidal vitamin d analogues
12/08/2005CA2566011A1 Method for producing quaternary ammonium compounds
12/08/2005CA2563335A1 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
12/07/2005EP1602641A1 Bis(3-amino-4-hydroxyphenyl)adamantane derivatives and process for production thereof
12/07/2005EP1602369A2 Bupropion Metabolites and Methods of their Synthesis and Use
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601640A2 Process for preparation of phenethylamine derivatives
12/07/2005CN1705634A Process for preparing (R) salbutamol
12/07/2005CN1704398A Method for one-step purification and separation of ephedrine by cation exchange resin and expanded bed integrated technology
12/07/2005CN1230417C Method of preparing primary amine and secondary amine from nitrile
12/06/2005CA2220389C Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2h-3,1-benzoxazin-2-one
12/06/2005CA2174431C Synthesis of sphingosines
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113559A1 Stereoselective method for the production of clopidogrel
12/01/2005WO2005113492A1 Cysteine analogues salts of ambroxol, preparation methods and uses thereof
12/01/2005WO2005113483A2 Levalbuterol hydrochloride polymorph a
12/01/2005WO2005113482A1 Levalbuterol hydrochloride polymorph b
12/01/2005WO2005113481A1 Preparation of levalbuterol hydrochloride
12/01/2005WO2005070873A3 Alkoxylated amines
12/01/2005WO2005056515A3 Use of bis-amines to enhance the antimicrobial activity of aqueous compositions
12/01/2005US20050267219 Enantiomers of N-desmethyl venlafaxine
12/01/2005US20050267216 suspending or forming a slurry of the R enantiomer of albuterol dibenzoyl tartrate complex in at least one solvent;adding hydrogen chloride in a C1-C4 alcohol to the suspension or slurry until levalbuterol hydrochloride Polymorph B is obtained
12/01/2005US20050267047 Diarylalkanes as potent inhibitors of binuclear enzymes
12/01/2005CA2563662A1 A stereoselectivce process for the preparation of clopidogrel
12/01/2005CA2556921A1 Levalbuterol hydrochloride polymorph b
12/01/2005CA2556920A1 Levalbuterol hydrochloride polymorph a
12/01/2005CA2556904A1 Preparation of levalbuterol hydrochloride
11/2005
11/29/2005CA2351528C Process for the preparation of a piperazine derivative
11/24/2005WO2005111002A2 Substituted cycloalkyl derivatives for use in the treatment of respiratory diseases
11/24/2005WO2005097731A3 Ionic liquids comprising nitrogen containing cations
11/24/2005WO2005092011A3 Mitotic kinesin inhibitors
11/24/2005US20050261514 Process for the enantioselective hydrogenation of amino alcohols
11/24/2005US20050261368 N-(tert-butyl)-2-methoxy-2-(4-hydroxy-3-(hydroxymethyl)phen-1-yl)-ethanamine; reduced steps for synthesis while maximizing synthetic yield without sacrificing compound purity; adding D-dibenzoyltartaric acid to mixture of racemic salbutamol in methanol; crystallizing, recrystalling in second solvent
11/24/2005US20050261338 Beta2-adrenergic receptor agonists
11/24/2005US20050261286 Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050260597 Transfection reagents
11/24/2005CA2565548A1 Substituted cycloalkyl derivatives for use in the treatment of respiratory diseases
11/23/2005EP1320522B1 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1699337A Ambroxol cysteine analogs and their preparation process and use thereof
11/23/2005CN1228335C Crystal choline ascorbate
11/22/2005US6967259 Process for the preparation of Citalopram intermediate
11/17/2005WO2005108381A1 Synthesis and uses of synephrine derivatives
11/17/2005US20050256318 Process for the preparation of n-monosubstituted beta-amino alcohols
11/16/2005EP1595873A1 Substituted cycloalkyl derivatives for the treatment of respiratory diseases
11/16/2005EP1594856A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
11/16/2005CN1697651A 1-phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
11/10/2005US20050250944 Synthesis and uses of synephrine derivatives
11/10/2005CA2649054A1 Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
11/09/2005EP1009731B1 Method for producing aryloligoamines
11/08/2005US6962995 Phenanthroline derivatives
11/03/2005WO2005103280A1 Process for producing optically active 4-(n-protected amino)-1-alken-3-ol and process for producing therefrom 3-benzamido-2-hydroxycarboxylic acid or salt thereof
11/03/2005US20050245607 N-bisaryl- and n-aryl-cylcloakylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
11/02/2005EP1591439A1 Ligands and complex compounds containing the same
11/02/2005EP1309540B1 Oxidizing colorant
11/02/2005EP1159261B1 Antizyme modulators and their use
11/01/2005US6960683 Antiinflammatory agents; autoimmune diseases; cardiovascular disorders
10/2005
10/27/2005WO2005100299A1 Process for preparation of optically active 1-erythro-2-amino-1-phenyl-1-propanol
10/27/2005US20050239896 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke, depression, glaucoma
10/27/2005US20050239790 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005US20050236980 Charge transport compositions and electronic devices made with such compounds
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 116